Bayer's Mirena Gets Approval In Europe For Extended Duration Of Use In Contraception

RTTNews | 735 일 전
Bayer's Mirena Gets Approval In Europe For Extended Duration Of Use In Contraception

(RTTNews) - German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Friday that Mirena (52mg LNG IUS), its long-acting reversible intrauterine system, received regulatory approval in the European Workshare Procedure for up to eight years in contraception. This is the longest contraceptive duration of use for any hormonal intrauterine system.

The levonorgestrel (LNG) releasing intrauterine system (IUS) Mirena has been approved for countries in Europe.

This regulatory approval in Europe is based on the results of the Mirena Extension Trial evaluating the efficacy and safety of Mirena which demonstrated that contraceptive efficacy remains high with greater than 99% during years six to eight of use.

Following the completion of the European Workshare procedure the first national approvals in the EU are expected in the fourth quarter of 2022.

The European approval also includes symptom driven extended use for the indication idiopathic menorrhagia (heavy menstrual bleeding) for up to eight years or until symptoms return.

In August 2022, Bayer received U.S. approval for the extended duration of use for up to eight years in the contraception indication for its levonorgestrel (LNG) releasing intrauterine system (IUS) Mirena.

A LNG-IUS is one of the most effective birth control methods as it does not require user compliance such as daily dosing or monthly re-fills. It can be removed by the doctor at any time.

For More Such Health News, visit rttnews.com

read more
Bayer Submits SNDA For Expanded Use Of NUBEQA In Metastatic Hormone-Sensitive Prostate Cancer To FDA

Bayer Submits SNDA For Expanded Use Of NUBEQA In Metastatic Hormone-Sensitive Prostate Cancer To FDA

German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for the oral androgen receptor inhibitor (ARi) NUBEQA (darolutamide) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC).
RTTNews | 23 일 전
Bayer Stock Climbs On US Legal Win In Roundup Cancer Claims

Bayer Stock Climbs On US Legal Win In Roundup Cancer Claims

Shares of Bayer AG were climbing around 11 percent in German trading after the pharmaceutical and life sciences major announced a favorable ruling in the United States in the lawsuit over cancer claims against its Roundup weed killer. In a statement, the company noted that the Third Circuit Court of Appeals issued its favorable ruling in Schaffner v. Monsanto...
RTTNews | 63 일 전
Bayer Q4 Profit Surges, Warns On FY24; Says Break-up Not Now

Bayer Q4 Profit Surges, Warns On FY24; Says Break-up Not Now

German pharmaceutical and biotechnology major Bayer AG reported Tuesday a surge in its fourth-quarter net profit benefited by weak expenses. Meanwhile, sales were hurt by lower Pharmaceuticals sales, despite growth in Crop Science and consumer Health segments. Further, the company trimmed its dividend, and said it sees lower adjusted earnings and nearly flat sales in fiscal 2024 on a currency-adju
RTTNews | 228 일 전
TSX Continues To Move Up North, Ends 0.53% Up At New High

TSX Continues To Move Up North, Ends 0.53% Up At New High

The Canadian market climbed to a new record high on Friday, rising for a third straight day, thanks to strong gains in materials stocks as metal prices surged to record highs. Continued optimism about interest rate cuts by the Bank of Canada also aided sentiment.
RTTNews | 14 시간 36 분 전
Dollar Turns Weak After Recent Gains

Dollar Turns Weak After Recent Gains

The U.S. dollar turned a bit weak on Friday, snapping a five-day winning streak, with global stocks moving higher on increased risk appetite after the Chinese government announced a couple of funding schemes.
RTTNews | 15 시간 14 분 전
TSX Rises To New High; Materials Shares Rally

TSX Rises To New High; Materials Shares Rally

The Canadian market is up firmly in positive territory Friday afternoon after posting a new high for the third straight day. Materials stocks are contributing to the move up north, with firm metal prices triggering hectic buying at several counters in the sector.
RTTNews | 18 시간 37 분 전
Canadian Dollar Weakens As Oil Prices Fall

Canadian Dollar Weakens As Oil Prices Fall

The Canadian dollar declined against its most major counterparts in the New York session on Friday, as oil prices dropped on concerns about slowing demand from China.
RTTNews | 18 시간 55 분 전
Swiss Market Closes Modestly Higher

Swiss Market Closes Modestly Higher

The Switzerland market ended modestly higher on Friday after a choppy ride as investors looked ahead to more interest rate cuts from central banks after the European Central Bank cut rates for the third time this year.
RTTNews | 19 시간 3 분 전